Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) [Phase 2]
Phase 2 study P02143 evaluating temozolomide for brain metastases from non-small-cell lung cancer has been terminated. The sponsor is Merck …
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD) [Phase 2]
Phase 2 trial evaluating concurrent and non-concurrent chemotherapy with radiotherapy, or radiotherapy alone, using intensity-modulated radi…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating pemetrexed disodium in combination with cisplatin for patients undergoing surgery for stages I–III non-small cell l…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Clinical trial update describing a correlative study using blood and tissue samples from patients with non-small cell lung cancer treated wi…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) [Phase 2]
Phase 2 study of PRO95780 in previously untreated, advanced-stage non-small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Bone Metastasis on the Survival of Gefitinib Effective Patients [NA]
A completed clinical trial update examining the impact of bone metastasis on survival outcomes in non-small cell lung cancer patients treate…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
This update describes the investigation of HER-2 mutations in tumor samples from patients with advanced non-small cell lung cancer who were …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate
A completed clinical trial analyzing blood biomarkers in patients with refractory non-small cell lung cancer who were previously treated wit…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer [Phase 2]
Phase 2 study assessing dovitinib with biomarkers in advanced non-small cell lung cancer and advanced colorectal cancer has completed with p…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial of GSK1572932A as adjuvant therapy in tumor-antigen-positive non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC [Phase 2]
This Phase 2 trial evaluating cisplatin with nab-paclitaxel for Stage IIIA non-small cell lung cancer has been terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating stereotactic body radiation therapy for stage I non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) [Phase 2]
Phase 2 study evaluating temozolomide for brain metastases from melanoma, breast cancer, or non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing Genexol (paclitaxel) plus cisplatin versus Genexol-PM (paclitaxel-loaded micelle) plus cisplatin in advanced Non-Sma…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) [Phase 2]
Phase 2 trial of temozolomide for brain metastases from non-small cell lung cancer has completed; the study status is listed as COMPLETED.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib [Phase 2]
Phase 2 study of LDK378 (alectinib) in adults with ALK-activated non-small cell lung cancer who were previously treated with chemotherapy an…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial testing Erlotinib and Cetuximab in patients with advanced solid tumors, with emphasis on …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK
A completed clinical trial evaluating neutropenic sepsis and related resource use in non-small cell lung cancer patients treated with single…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs [Phase 2]
This entry describes a Phase 2 clinical trial evaluating high-dose pulsatile erlotinib or gefitinib in patients with advanced non-small cell…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy [Phase 2]
A Phase 2 study evaluating a high-dose icotinib regimen in patients with advanced non-small cell lung cancer after failure of prior targeted…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Hypermetabolism in the Elderly Lung Cancer Patient
A completed clinical trial examining hypermetabolism in elderly patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 3]
Phase 3 trial comparing high-dose or standard-dose radiation therapy with chemotherapy, with or without cetuximab, in newly diagnosed stage …
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Endobronchial Ultrasound vs Mediastinoscopy in NSCLC [Phase 2]
A Phase 2 trial comparing endobronchial ultrasound with mediastinoscopy for mediastinal evaluation in non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)
An observational study evaluating erlotinib (Tarceva) in participants with locally advanced or metastatic non-small cell lung cancer (adenoc…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific [Phase 2]
Phase II single-arm trial of AZD9291 (osimertinib) for non-small cell lung cancer patients in the Asia-Pacific region has completed and resu…